Eva Kleine

1.8k total citations · 1 hit paper
38 papers, 1.1k citations indexed

About

Eva Kleine is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Eva Kleine has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 6 papers in Surgery. Recurrent topics in Eva Kleine's work include Atrial Fibrillation Management and Outcomes (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Cardiac Arrhythmias and Treatments (11 papers). Eva Kleine is often cited by papers focused on Atrial Fibrillation Management and Outcomes (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Cardiac Arrhythmias and Treatments (11 papers). Eva Kleine collaborates with scholars based in Germany, United States and United Kingdom. Eva Kleine's co-authors include Gregory Y.H. Lip, Jurriën M. ten Berg, Stefan H. Hohnloser, Matias Nordaby, Jonas Oldgren, Christopher P. Cannon, Deepak L. Bhatt, Philippe Gabríel Steg, Takeshi Kimura and Béla Merkely and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Eva Kleine

36 papers receiving 1.1k citations

Hit Papers

Dual Antithrombotic Therapy with Dabigatran after PCI in ... 2017 2026 2020 2023 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
    2017 843 citations Christopher P. Cannon, Deepak L. Bhatt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Kleine Germany 10 1.1k 405 176 89 75 38 1.1k
Francisco Pérez-Gómez Spain 8 519 0.5× 206 0.5× 125 0.7× 130 1.5× 46 0.6× 14 663
Anna Gundlund Denmark 11 436 0.4× 97 0.2× 48 0.3× 36 0.4× 69 0.9× 25 475
David Burkhardt United States 20 1.5k 1.4× 55 0.1× 82 0.5× 39 0.4× 69 0.9× 42 1.5k
Yan‐Guang Li China 16 669 0.6× 62 0.2× 43 0.2× 133 1.5× 75 1.0× 38 763
Christopher E. Hilker United States 5 958 0.9× 91 0.2× 84 0.5× 141 1.6× 99 1.3× 6 1.0k
Gregory F. Michaud United States 13 1.0k 0.9× 44 0.1× 105 0.6× 27 0.3× 41 0.5× 23 1.1k
Yee Cheng Lau United Kingdom 8 295 0.3× 97 0.2× 52 0.3× 46 0.5× 31 0.4× 23 365
Line Melgaard Denmark 8 303 0.3× 79 0.2× 27 0.2× 76 0.9× 47 0.6× 14 362
Simon Sporton United Kingdom 22 1.6k 1.4× 45 0.1× 95 0.5× 20 0.2× 93 1.2× 83 1.6k
Alessandro Spirito United States 11 337 0.3× 36 0.1× 164 0.9× 128 1.4× 60 0.8× 48 416

Countries citing papers authored by Eva Kleine

Since Specialization
Citations

This map shows the geographic impact of Eva Kleine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kleine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kleine more than expected).

Fields of papers citing papers by Eva Kleine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kleine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kleine. The network helps show where Eva Kleine may publish in the future.

Co-authorship network of co-authors of Eva Kleine

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kleine. A scholar is included among the top collaborators of Eva Kleine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kleine. Eva Kleine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brutto, Víctor J. Del, Hans‐Christoph Diener, J. Donald Easton, et al.. (2022). Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial. Journal of the American Heart Association. 11(11). e023545–e023545. 8 indexed citations
2.
Albisetti, Manuela, Igor Tartakovsky, Jacqueline Halton, et al.. (2021). Abstract 9192: Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children With Congenital Heart Disease. Circulation. 144(Suppl_1). 1 indexed citations
3.
Diener, Hans‐Christoph, Aurauma Chutinet, J. Donald Easton, et al.. (2021). Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale. Stroke. 52(3). 1065–1068. 22 indexed citations
4.
Peterson, Benjamin E., Deepak L. Bhatt, Philippe Gabríel Steg, et al.. (2021). Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. JACC: Cardiovascular Interventions. 14(7). 768–780. 5 indexed citations
5.
Caterina, Raffaele De, Dimitar Raev, Shamir R. Mehta, et al.. (2020). Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. The American Journal of Medicine. 133(11). 1302–1312. 3 indexed citations
6.
Berg, Jurriën M. ten, Jonas Oldgren, Philippe Gabríel Steg, et al.. (2019). Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation. JACC: Cardiovascular Interventions. 12(23). 2331–2341. 6 indexed citations
7.
Hohnloser, Stefan H., Hugh Calkins, Stephan Willems, et al.. (2019). Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study. Journal of Interventional Cardiac Electrophysiology. 55(2). 145–152. 1 indexed citations
8.
Lip, Gregory Y.H., Laura Mauri, Gilles Montalescot, et al.. (2018). RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL. Journal of the American College of Cardiology. 71(11). A289–A289. 1 indexed citations
9.
Steg, Philippe Gabríel, Deepak L. Bhatt, Stephen J. Ellis, et al.. (2018). BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT. Journal of the American College of Cardiology. 71(11). A1154–A1154. 1 indexed citations
10.
Hohnloser, Stefan H., Philippe Gabríel Steg, Jonas Oldgren, et al.. (2018). DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI. Journal of the American College of Cardiology. 71(11). A314–A314. 2 indexed citations
11.
Oldgren, Jonas, Philippe Gabríel Steg, Stefan H. Hohnloser, et al.. (2017). Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Circulation. 136(24). 2 indexed citations
12.
Samama, Charles Marc, Nadia Rosencher, Eva Kleine, et al.. (2016). Observational study of dabigatran etexilate 150 mg in patients with moderate renal impairment undergoing elective total hip or knee replacement. Thrombosis Research. 143. 103–110. 4 indexed citations
13.
14.
Pollack, Charles V., Fredrik Gruenenfelder, Jerrold H. Levy, et al.. (2016). HEALTH CARE RESOURCE UTILIZATION IN PATIENTS REQUIRING URGENT SURGICAL/INTERVENTIONAL MANAGEMENT WHILE TAKING DABIGATRAN: INTERIM RESULTS FROM THE RE-VERSE AD STUDY. Journal of the American College of Cardiology. 67(13). 669–669. 1 indexed citations
15.
Verdecchia, Paolo, Giuseppe Di Pasquale, Gianpaolo Reboldi, et al.. (2016). EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 67(13). 884–884. 1 indexed citations
16.
17.
Wurnig, Christian, Andreas Clemens, Helmuth Rauscher, et al.. (2015). Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery. Thrombosis Journal. 13(1). 37–37. 4 indexed citations
18.
Parise, Helen, Martina Brueckmann, Eva Kleine, et al.. (2014). The use of dabigatran according to body mass index : the RE-LY experience. European Heart Journal. 35. 1111–1111. 10 indexed citations
19.
Hensen, J., et al.. (2007). Management of Diabetes Mellitus and Hospital-related Hyperglycemia in Patients of a Medical ICU, with the Use of Two “Down-to-Earth” Protocols: A Feasibility Study. Experimental and Clinical Endocrinology & Diabetes. 115(9). 577–583. 4 indexed citations
20.
Kleine, Eva. (1951). NASOFORM SPLINT: An External Nasal Splint for General Use. Archives of Otolaryngology - Head and Neck Surgery. 54(4). 422–425. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Pérez-Gómez Breakdown of academic impact, for papers by Anna Gundlund Breakdown of academic impact, for papers by David Burkhardt Breakdown of academic impact, for papers by Yan‐Guang Li Breakdown of academic impact, for papers by Christopher E. Hilker Breakdown of academic impact, for papers by Gregory F. Michaud Breakdown of academic impact, for papers by Yee Cheng Lau Breakdown of academic impact, for papers by Line Melgaard Breakdown of academic impact, for papers by Simon Sporton Breakdown of academic impact, for papers by Alessandro Spirito
Rankless by CCL
2026